If you received a letter after your mammogram saying your breasts are dense, the most important takeaway is this: it's a prompt for a risk discussion, not an automatic order for additional imaging. A new study published in March 2026 in Annals of Internal Medicine offers clearer guidance on when supplemental MRI screening actually makes sense for women with dense breast tissue.

What Does a Dense Breast Notice Actually Mean?

Since September 10, 2024, the FDA (Food and Drug Administration) has required mammography facilities nationwide to inform patients whether their breast tissue is dense. This new requirement has left many people wondering what comes next .

Breast density describes how much fibrous and glandular tissue appears on a mammogram compared with fatty tissue. Radiologists categorize breast density into four levels :

• Almost entirely fatty: Mostly fat tissue with minimal dense areas
• Scattered areas of fibroglandular density: Some dense tissue mixed with fat
• Heterogeneously dense: Considered "dense" with a mix of dense and fatty tissue
• Extremely dense: Considered "dense" with predominantly dense tissue throughout

According to the CDC, about half of women age 40 and older have dense breasts. The key point: breast density is not something you can feel by touch, and it does not mean your breasts are abnormal .

Why Does Breast Density Matter for Cancer Risk?

Dense breast tissue creates two challenges. First, dense breasts are linked to a somewhat higher risk of breast cancer. Second, dense tissue can make mammograms harder to read because both dense tissue and tumors appear white on the image. In other words, dense tissue can partially hide a cancer, making it harder for radiologists to spot .

However, "dense" is not a single risk category. Someone with heterogeneously dense breasts faces a different situation than someone with extremely dense breasts. Overall cancer risk still matters significantly when deciding on screening strategy .

What Did the New 2026 Study Actually Find?

Researchers from the Breast Cancer Surveillance Consortium conducted a modeling study published in Annals of Internal Medicine to estimate what might happen over a lifetime under different screening strategies. The study compared digital breast tomosynthesis (3D mammography) with or without supplemental MRI across different starting ages, screening intervals, breast density levels, and cancer risk levels ranging from average risk to four times average risk .

The headline finding was not that all women with dense breasts should get MRI. Instead, the most favorable balance appeared in women with extremely dense breasts and at least roughly double average breast cancer risk. The study concluded that supplemental MRI for women with extremely dense breasts and higher-than-average risk had harm-benefit ratios similar to biennial 3D mammography alone and could be cost-effective if MRI costs and false-positive biopsy rates were lower .

This is a narrower message than many readers expect. It does not mean every person with a dense breast notice should add MRI. It also does not mean the study proved MRI saves lives for all women with dense breasts .

What Are the Tradeoffs of Adding MRI Screening?

The model showed important tradeoffs. Across different ages and screening intervals, adding MRI for women with extremely dense breasts prevented a small additional number of breast cancer deaths but also led to many more false-positive biopsy recommendations .

MRI is a very sensitive test, which can be helpful for people at higher risk. But higher sensitivity also means more findings that turn out not to be cancer. This creates a cascade of additional testing and stress :

• More call-backs: Additional appointments after screening to discuss findings
• More follow-up imaging: Extra ultrasounds, mammograms, or other imaging tests
• More biopsy recommendations: Procedures to sample tissue and confirm whether findings are cancer
• More anxiety: Stress and worry while waiting for answers about abnormal findings
• More cost: Out-of-pocket expenses for additional tests not covered by insurance

The CDC notes that extra tests after a mammogram are more likely to produce false-positive results, which can lead to unnecessary testing and biopsies. The new study reached a similar conclusion from a modeling perspective: whether MRI looked cost-effective depended heavily on MRI price and on how often it triggered false-positive biopsy recommendations .

How to Decide If You Need Extra Screening Beyond Mammography

Current U.S. guidance does not treat dense breasts alone as an automatic reason for extra screening. The American College of Obstetricians and Gynecologists (ACOG) does not recommend routine extra screening for people who have dense breasts but no other risk factors and no symptoms, because evidence has not clearly shown that adding other tests for dense breasts alone reduces deaths from breast cancer .

If you get a dense breast notice, ask your clinician these specific questions to determine your personalized screening plan :

• Density level: Do I have heterogeneously dense breasts or extremely dense breasts?
• Family history: How does my family history affect my risk for breast cancer?
• Personal risk factors: Do I have any personal history, biopsy findings, or genetic factors like BRCA mutations that put me at higher risk?
• Screening options: Would MRI, ultrasound, or no extra test be most appropriate for my situation?
• Insurance coverage: Will my insurance cover supplemental screening, and what could I owe out of pocket?

Coverage can vary significantly, and extra imaging may still bring out-of-pocket costs depending on the test, the plan, and where you receive care. That is worth checking before scheduling additional screening .

What Factors Beyond Density Affect Your Breast Cancer Risk?

Dense breasts are only one piece of the risk puzzle. Multiple factors can change what screening plan makes sense for you. These include family history, inherited mutations such as BRCA-related risk, prior high-risk biopsy findings, prior chest radiation at a young age, and personal breast cancer history .

The goal of modern breast cancer screening is to find the people most likely to benefit without causing a large amount of extra harm, cost, and stress for everyone else. That is why "more screening" is not always the same as "better screening" .

A dense breast letter should not be ignored, but it also should not trigger panic. Dense breasts are common and can modestly raise breast cancer risk and make mammograms harder to read. However, the new March 2026 study does not support automatic MRI for everyone with dense tissue. Its main message is more targeted: supplemental MRI may make the most sense for people with extremely dense breasts who also have other risk factors that put them above average risk .

For everyone else, the best next step is usually a conversation about overall risk, not a rush into more imaging. And none of this means you should skip mammograms. Mammography remains the starting point for screening, with extra tests considered when the likely benefit is high enough to outweigh the added false alarms, biopsies, and costs .